Investor Briefing
4 March 2019 Investor Briefing – Non-Deal Roadshow Download PDF to read...
Read More
Appendix 4D Half Yearly Report
Melbourne, Australia, 26 February 2019 CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company...
Read More
CLINUVEL Vitiligo Communiqué II
12 February 2019 In the second Communiqué we look closer at...
Read More
CLINUVEL Newsletter - February 2019
7 February 2019 Dear patients, shareholders, friends, In this second Communiqué for...
Read More
Appendix 4C
31 January 2019 Melbourne, Australia and Leatherhead, UK CLINUVEL PHARMACEUTICALS LTD, a...
Read More
Change of Director's Interest Notice
Melbourne, Australia 29 January 2019 The following Appendix 3Y Change of Director’s...
Read More
CLINUVEL Newsletter - January 2019
15 January 2019 Dear patients, shareholders, friends, I wish you all a...
Read More
US FDA sets PDUFA date for SCENESSE®
Melbourne, Australia 10 January 2019 Priority Review granted for innovative drug, PDUFA...
Read More